Literature DB >> 23257206

Variable domain antibodies specific for viral hemorrhagic septicemia virus (VHSV) selected from a randomized IgNAR phage display library.

Maki Ohtani1, Jun-ichi Hikima, Tae-Sung Jung, Hidehiro Kondo, Ikuo Hirono, Haruko Takeyama, Takashi Aoki.   

Abstract

Phage display libraries are used to screen for nucleotide sequences that encode immunoglobulin variable (V) regions that are specific for a target antigen. We previously constructed an immunoglobulin new antigen receptor (IgNAR) phage display library. Here we used this library to obtain an IgNAR V region that is specific for viral hemorrhagic septicemia virus (VHSV). A phage clone (clone 653) was found to be specific for VHSV by the biopanning method. The V region of clone 653 was used to construct a 6 × His tagged recombinant IgNAR-653 V protein (rIgNAR-653) using the Escherichia coli pET system. The rIgNAR-653 protein bound specifically to VHSV, confirming its activity.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23257206     DOI: 10.1016/j.fsi.2012.11.041

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  3 in total

1.  Overview, Generation, and Significance of Variable New Antigen Receptors (VNARs) as a Platform for Drug and Diagnostic Development.

Authors:  Samata S Pandey; Marina Kovaleva; Caroline J Barelle; Obinna C Ubah
Journal:  Methods Mol Biol       Date:  2022

2.  Structural insights and biomedical potential of IgNAR scaffolds from sharks.

Authors:  Stefan Zielonka; Martin Empting; Julius Grzeschik; Doreen Könning; Caroline J Barelle; Harald Kolmar
Journal:  MAbs       Date:  2015       Impact factor: 5.857

3.  Isolation and characterization of malaria PfHRP2 specific VNAR antibody fragments from immunized shark phage display library.

Authors:  Chiuan Herng Leow; Katja Fischer; Chiuan Yee Leow; Katleen Braet; Qin Cheng; James McCarthy
Journal:  Malar J       Date:  2018-10-24       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.